Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers

NCT01776437 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer